Back to search

Denmark· DK-28106044517

Esketamine "Orifarm"

A esketamine product containing esketaminhydrochlorid, registered in Denmark by Orifarm Generics A/S. The same ATC class is registered in 8 of our 19 countries.

ATC N01AX14

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedEsketamine "Orifarm"ATCN01AX14REGISTER NO.DK-28106044517PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Esketamine is registered in 8 of 19 countries.

Countries holding a registration under ATC N01AX14 (esketamine), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 5 of them publish a price we can compare per daily dose

Esketamine · ATC N01AX14

8 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
Esketaminhydrochlorid
Manufacturer
Orifarm Generics A/S
Country
Denmark (DK)
ATC code
N01AX14
ATC class
Esketamine
Defined daily dose
0.125 g, P
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28106044517

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

91 interactions on record for esketamine.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Esketamine · interactions on record

91 records

  • 7 severe
  • 84 moderate

Most severe, free to view

  • PhentermineA08AA01severe
  • FenfluramineA08AA02severe
  • MazindolA08AA05severe
  • FenfluramineN03AX26severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fc0a7a29-8764-4d63-96bb-40b8191ea6dc
GET /v1/drugs/fc0a7a29-8764-4d63-96bb-40b8191ea6dc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "injektions-/infusionsvæske, opløsning",
  "source": "dkma",
  "strength": "5 mg/ml",
  "auth_role": "RMS",
  "dk_drugid": "28106044517",
  "substance": "Esketaminhydrochlorid",
  "auth_procedure": "Decentral procedure",
  "in_medicinpriser": true,
  "registration_date_serial": "43643"
}

See everything about esketamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.